Baseline and early on-treatment HBsAg level to predict HBsAg loss in nucleotide analog suppressed and HBeAg cleared chronic hepatitis B patients by switching to peginterferon alfa-2a: exploratory results of NEW SWITCH study

被引：0
|
作者：
Hu, P. [1 ]
Xie, Q. [2 ]
Li, Y. [3 ,11 ]
Chen, X. [4 ,19 ]
Dou, X. [5 ]
Jiang, J. [6 ,20 ]
Shang, J. [7 ]
Zhang, W. [8 ]
Gong, G. [9 ]
Sun, Y. [10 ]
Li, Y. [3 ,11 ]
Liu, Y. [12 ]
Liu, G. [13 ]
Mao, D. [14 ]
Chi, X. [15 ]
Tang, H. [16 ]
Li, X. [17 ]
Xie, Y. [18 ]
Chen, X. [4 ,19 ]
Jiang, J. [6 ,20 ]
Zhao, P. [21 ]
Hou, J. [22 ]
Gao, Z. [23 ]
Fan, H. [24 ]
Ding, J. [25 ]
Ren, H. [1 ]
机构：
[1] Chongqing Med Univ, Infect Dis, Affiliated Hosp 2, Chongqing, Peoples R China
[2] Shanghai Jiao Tong Univ, Infect Dis, Ruijin Hosp, Sch Med, Shanghai, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China
[4] Capital Med Univ, Int Med Dept, Beijing YouAn Hosp, Beijing, Peoples R China
[5] China Med Univ, Shengjing Hosp, Infect Dis, Shenyang, Peoples R China
[6] Guangxi Med Univ, Affiliated Hosp 1, Infect Dis, Nanning, Peoples R China
[7] Henan Prov Peoples Hosp, Infect Dis, Zhengzhou, Peoples R China
[8] Fudan Univ, Huashan Hosp, Infect Dis, Shanghai, Peoples R China
[9] Cent S Univ, Xiangya Hosp 2, Infect Dis, Changsha, Hunan, Peoples R China
[10] Fourth Mil Med Univ, Infect Dis, Tangdu Hosp, Xian, Peoples R China
[11] Ningxia Med Univ, Infect Dis, Gen Hosp, Yinchuan, Peoples R China
[12] Shenzhen Third Peoples Hosp, Liver Dis Dept, Shenzhen, Peoples R China
[13] Cent S Univ, Infect Dis, Xiangya Hosp, Changsha, Hunan, Peoples R China
[14] Guangxi Univ Chinese Med, Liver Dis Dept, Affiliated Hosp 1, Nanning, Peoples R China
[15] Guangdong Hosp Tradit Chinese Med, Liver Dis Dept, Guangzhou, Guangdong, Peoples R China
[16] Sichuan Univ, Infect Dis, West China Hosp, Chengdu, Peoples R China
[17] Sixth Peoples Hosp Hangzhou, Liver Dis Dept, Hangzhou, Zhejiang, Peoples R China
[18] Capital Med Univ, Beijing Ditan Hosp, Liver Dis Dept, Beijing, Peoples R China
[19] Guangdong Gen Hosp, Infect Dis, Guangzhou, Guangdong, Peoples R China
[20] Fujian Med Univ, Affiliated Hosp 1, Liver Dis Dept, Fuzhou, Peoples R China
[21] 302 Hosp PLA, Int Ctr Liver Dis Treatment, Beijing, Peoples R China
[22] Southern Med Univ, Nanfang Hosp, Infect Dis, Guangzhou, Guangdong, Peoples R China
[23] Sun Yat Sen Univ, Affiliated Hosp 3, Infect Dis, Guangzhou, Guangdong, Peoples R China
[24] Guangzhou Eighth Peoples Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China
[25] Ruian Peoples Hosp, Hepatol Unit, Ruian, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30842-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-175
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [1] ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
    Lau, G. K. K.
    Marcellin, P.
    Brunetto, M.
    Piratvisuth, T.
    Kapprell, H. -P
    Messinger, D.
    Popescu, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S333 - S333
  • [2] BASELINE HBsAg LEVEL PREDICT HBsAg LOSS IN CHRONIC HEPATITIS B PATIENTS TREATED WITH A COMBINATION OF PEGINTERFERON ALFA-2A AND ADEFOVIR: AN INTERIM ANALYSIS
    Takkenberg, B.
    Zaaijer, H.
    Weegink, C.
    Terpstra, V.
    Dijkgraaf, M.
    Jansen, P.
    Janssen, H.
    Beld, M.
    Reesink, H.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S8 - S8
  • [3] BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 536A - 537A
  • [4] BASELINE HBSAG LEVEL AND ON-TREATMENT HBSAG AND HBV DNA DECLINE PREDICT SUSTAINED VIROLOGICAL RESPONSE IN HBEAG NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA); AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 538A - 539A
  • [5] BASELINE HBSAG AS PREDICTOR FOR HBSAG SEROCONVERSION IN HBEAG NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A AND ADEFOVIR: FINAL RESULTS OF A PROSPECTIVE OPEN LABEL STUDY
    Takkenberg, Bart
    de Niet, Annikki
    Zaaijer, Hans L.
    Weegink, Christine J.
    Terpstra, Valeska
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Rijckborst, Vincent
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2011, 54 : 1039A - 1040A
  • [6] Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels
    Rijckborst, Vincent
    Hansen, Bettina E.
    Cakaloglu, Yilmaz
    Ferenci, Peter
    Tabak, Fehmi
    Akdogan, Meral
    Simon, Krzysztof
    Akarca, Ulus S.
    Flisiak, Robert
    Verhey, Elke
    Van Vuuren, Anneke J.
    Boucher, Charles A. B.
    ter Borg, Martijn J.
    Janssen, Harry L. A.
    HEPATOLOGY, 2010, 52 (02) : 454 - 461
  • [7] On-treatment HBsAg level and HBeAg index can early predict HBeAg seroconversion in chronic hepatitis B, HBeAg positive patients treated with peginterferon alpha-2a
    Phisalprapa, P.
    Charatcharoenwitthaya, P.
    Chainuwatti, S.
    Nimanong, S.
    Pausawasdi, N.
    Prachayakul, V.
    Pongprasobchai, S.
    Udompanthurak, S.
    Leelakusolvong, S.
    Manatsathit, S.
    Kachintorn, U.
    Tanwandee, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A94 - A94
  • [8] ON-TREATMENT HBSAG LEVEL AND HBEAG INDEX CAN EARLY PREDICT HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B, HBEAG POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2A
    Phisalprapa, Pochamana
    Charatcharoenwitthaya, Phunchai
    Chainuvati, Siwaporn
    Nimanong, Supot
    Prachayakul, Varayu
    Pausawasdi, Nonthalee
    Pongprasobchai, Supot
    Leelakusolvong, Somchai
    Manatsathit, Sathaporn
    Kachintorn, Udom
    Tanwandee, Tawesak
    HEPATOLOGY, 2010, 52 (04) : 526A - 527A
  • [9] IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B HBSAG SERUM LEVELS EARLY DURING TREATMENT WITH PEGINTERFERON ALFA-2A PREDICT HBSAG CLEARANCE 4 YEARS POST-TREATMENT
    Marcellin, Patrick
    Brunetto, Maurizia
    Bonino, Ferruccio
    Hadziyannis, Stephanos J.
    Kapprell, Hans-Peter
    McCloud, Philip I.
    Batrla, Richard
    HEPATOLOGY, 2008, 48 (04) : 718A - 719A
  • [10] Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
    Peng, C. -Y.
    Lai, H. -C.
    Li, Y. -F.
    Su, W. -P.
    Chuang, P. -H.
    Kao, J. -T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (04) : 458 - 468
12345